Patent Number:
6,165,507
Title:
Slow-release pharmaceutical formulations containing mizolastine
Abstract:
A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
Inventors:
Chariot; Maryvonne (La Ville du Bois, FR), Lewis; Gareth (Dourdan, FR), Montel; Jean (Chatou, FR)
Assignee:
Synthelabo
International Classification:
A61K 9/20 (20060101); A61K 9/28 (20060101); A61K 31/506 (20060101); A61K 009/22 (); A61K 009/36 (); A61K 009/14 (); A61K 031/505 ()
Expiration Date:
12/26/2017
